Work

Role of claudin-6 in high-grade endometrial carcinoma: Implications for risk stratification and personalized treatment strategies

Year: 2026

Type: article

Abstract: on the role of claudin-6 (CLDN6) in high-grade endometrial carcinoma, addressing a significant gap in current knowledge. Their research reveals that overexpression of CLDN6 is linked to unfavorable pathological features. Moreover, multivariate analysis establishes CLDN6 as an independent predictor of disease-free survival, with a hazard ratio of 68.98. These results highlight the promise of CLDN6 in improving risk stratification and as a potential therapeutic target, especially with the development of CLDN6-directed antibody-drug conjugates. To advance CLDN6 towards clinical application, further validation in prospective patient cohorts and studies exploring its interactions with other molecular pathways are essential.

Source: World Journal of Clinical Oncology

DOI: 10.5306/wjco.v17.i2.116390

Authors: Chuang Cai, Jin-Man Chen, Zu-Xun Qiu, Shu-Qi Ren

Institutions: Zhongshan People's Hospital, Guangzhou University of Chinese Medicine

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

Funder: Universitat Autònoma de Barcelona